Core Insights - The collagen industry is experiencing dual opportunities of demand expansion and track upgrades, with applications extending from traditional health sectors to new materials and textiles [1] - Dongbao Biological Technology Co., Ltd. is leveraging its full industry chain advantages and "Collagen+" strategy to explore differentiated development paths [1][3] Company Development History - Dongbao Biological, established over 60 years ago, began as a gelatin manufacturer and has evolved through various stages, including a successful listing on the Shenzhen Stock Exchange in 2011 [3][4] - The company has transitioned from traditional production methods to a focus on quality improvement and product diversification, including the introduction of hollow capsule business in 2021 [3][4] Strategic Focus - The company emphasizes its core collagen business, ensuring resource concentration and maximum efficiency in production and business expansion [4] - Dongbao is actively pursuing "Collagen+" strategy to expand into emerging fields such as new materials and textiles, aiming to create differentiated competitive advantages [5][6] Research and Innovation - Dongbao collaborates with domestic universities and research institutions to develop specialized collagen products for various applications, including textiles and energy technology [6][7] - Innovations include customized collagen for wool and low-temperature dyeing agents, enhancing fabric durability and reducing energy consumption [7] Market Strategy - The company is implementing a dual-market strategy focusing on domestic deepening and high-end expansion, while also targeting emerging fields [8] - By 2025, Dongbao aims to commercialize high-end collagen products and establish partnerships with well-known enterprises [8] Future Outlook - Dongbao plans to focus on high-end, international, and new emerging fields as its three strategic priorities moving forward [9] - The company aims to continuously innovate and enhance its product matrix, solidifying its competitive advantage in the full industry chain [9]
东宝生物:推进“胶原+”战略 探索差异化发展之路